Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...

A 23-year-old white woman with systemic lupus erythematosus (SLE ... During the acute stage of the infarction, diffusion-weighted MRI provides the best chance to distinguish acute from pre ...

The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

Ablynx’s vobarilizumab has failed in a mid-stage trial in lupus ... active seropositive systemic lupus erythematosus (SLE) across five treatment arms (four dose regimens of vobarilizumab ...